Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetic Neuropathy

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...

Diabetic Foot Ulcer

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...

Diabetic Nephropathy

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...

Cellular Injury IV: Necrosis

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...

Diabetic Ketoacidosis l: Introduction

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Serum Total CO2 of <22 mmol/l vs <18 mmol/l is an Appropriate Intervention Threshold in CKD Patients: CON.

Kidney360·2026

Same author

Pathophysiology of Ketoacidosis: Core Curriculum 2026.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Same author

The Sexual Dimorphism in Kidney Potassium Handling: A Conceptual Review.

Clinical journal of the American Society of Nephrology : CJASN·2026

Same author

Real-World Insights on Attitudes and Treatment of Hyperkalemia.

Mayo Clinic proceedings·2026

Same author

Sodium reduction and salt substitutes: impact on blood pressure and recurrent stroke.

Current opinion in cardiology·2026

Same author

Systemic effects of metabolic acidosis.

Clinical nephrology·2026

Search research articles

Related Experiment Video

Updated: Jul 7, 2026

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

Diabetic muscle necrosis.

Amir Said Alizadeh Naderi¹, Farnas Nematollah Farsian, Biff F Palmer

¹Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. anader@parknet.pmh.org

Journal of Diabetes and Its Complications

|February 19, 2008

Summary

Diabetic myonecrosis is an underdiagnosed condition affecting patients with diabetes. This report reviews its pathophysiology, diagnosis, management, and prognosis to aid clinical recognition.

More Related Videos

Static Strength Training Method for Type 2 Diabetic Mice

Static Strength Training Method for Type 2 Diabetic Mice

Published on: March 29, 2024

Related Experiment Videos

Last Updated: Jul 7, 2026

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

Static Strength Training Method for Type 2 Diabetic Mice

Static Strength Training Method for Type 2 Diabetic Mice

Published on: March 29, 2024

Area of Science:

Endocrinology
Neurology
Musculoskeletal Diseases

Background:

Diabetic myonecrosis is a rare complication of diabetes mellitus.
It is characterized by spontaneous, atraumatic muscle infarction.

Observation:

The case report details a patient presenting with symptoms suggestive of diabetic myonecrosis.
Clinical examination and diagnostic workup were performed.

Findings:

The patient was diagnosed with diabetic myonecrosis.
Discussion covers the pathophysiology, diagnostic criteria, and treatment options.

Implications:

Increased awareness among clinicians is crucial for early diagnosis and management.
Prompt recognition can improve patient outcomes and prevent long-term disability.